206 related articles for article (PubMed ID: 22512415)
1. Relative levels of the inflammatory cytokine TNFα and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves' disease.
Yamamoto K; Itoh M; Okamura T; Kimura M; Yokoyama A; Yoshino Y; Makino M; Hayakawa N; Suzuki A
Thyroid; 2012 May; 22(5):516-21. PubMed ID: 22512415
[TBL] [Abstract][Full Text] [Related]
2. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
3. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease.
Metwalley KA; Farghaly HS; Raafat DM; Ismail AM; Saied GM
J Clin Res Pediatr Endocrinol; 2020 Jun; 12(2):197-201. PubMed ID: 31782290
[TBL] [Abstract][Full Text] [Related]
5. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Nanba T; Watanabe M; Inoue N; Iwatani Y
Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
[TBL] [Abstract][Full Text] [Related]
6. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokines levels in Graves' disease.
Al-Humaidi MA
Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure.
Pignatelli P; Cangemi R; Celestini A; Carnevale R; Polimeni L; Martini A; Ferro D; Loffredo L; Violi F
Cardiovasc Res; 2008 Jun; 78(3):515-22. PubMed ID: 18281372
[TBL] [Abstract][Full Text] [Related]
9. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
[TBL] [Abstract][Full Text] [Related]
10. The role of osteopontin in the induction of the CD40 ligand in Graves' disease.
Qi Y; Li X; Ma X; Xu L; Zhang X; Jiang X; Hong J; Cui B; Ning G; Wang S
Clin Endocrinol (Oxf); 2014 Jan; 80(1):128-34. PubMed ID: 23617736
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
[TBL] [Abstract][Full Text] [Related]
12. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
[TBL] [Abstract][Full Text] [Related]
13. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR).
Heuer M; Aust G; Ode-Hakim S; Scherbaum WA
Thyroid; 1996 Apr; 6(2):97-106. PubMed ID: 8733879
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble CD40L concentration depending on the stage of multiple myeloma and its correlation with selected angiogenic cytokines.
Kamińska J; Koper OM; Dymicka-Piekarska V; Motybel-Iwańczuk E; Ołdziej A; Kemona H
Pol Arch Med Wewn; 2016 May; 126(5):321-9. PubMed ID: 27243341
[TBL] [Abstract][Full Text] [Related]
15. Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L.
Nagasawa M; Zhu Y; Isoda T; Tomizawa D; Itoh S; Kajiwara M; Morio T; Nonoyama S; Shimizu N; Mizutani S
Eur J Haematol; 2005 Jan; 74(1):54-60. PubMed ID: 15613107
[TBL] [Abstract][Full Text] [Related]
16. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
[TBL] [Abstract][Full Text] [Related]
17. Th1/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy.
Esfahanian F; Naimi E; Doroodgar F; Jadali Z
Iran J Allergy Asthma Immunol; 2013 May; 12(2):168-75. PubMed ID: 23754356
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease.
Fisfalen ME; Palmer EM; Van Seventer GA; Soltani K; Sawai Y; Kaplan E; Hidaka Y; Ober C; DeGroot LJ
J Clin Endocrinol Metab; 1997 Nov; 82(11):3655-63. PubMed ID: 9360522
[TBL] [Abstract][Full Text] [Related]
19. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
20. Increase of serum interleukin-10 in intractable Graves' disease.
Takeoka K; Watanabe M; Matsuzuka F; Miyauchi A; Iwatani Y
Thyroid; 2004 Mar; 14(3):201-5. PubMed ID: 15072702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
